Daiichi Sankyo Expands German Manufacturing Hub
Daiichi Sankyo Expands German Manufacturing Hub
GALWAY, IRELAND--March 5, 2024--Written by Martin Lynch, European News
Editor for Industrial Info (Galway, Ireland)--One of Japan's leading pharmaceutical companies, Daiichi Sankyo Propharma Company Limited has unveiled a 1 billion euro (US$1.09 billion) investment to expand its drug making operations in Germany.
Within this article: Details investment, timeline, company's push into cancer treatment sector, leading drugs in development, major deals with other players.
Subscribe Now!(All Fields Required)
Related Articles
Articles related to this company
- U.S. Supplement Production Brings Millions in Spending
- Samsung Biologics Constructing ADC Plant in South Korea
- Data Center Activity Propels Virginia to $12.7 Billion of Projects Under Co...
- Pharma Company Zoetis Signs PPA with Scout Clean Energy to Support Growing ...
- China's Rongsheng Petrochemical Ups Role in Polyester Chips